- Compass Pathways CEO on Trump's Order to Expand Psychedelics Research Bloomberg —
- FDA's Makary on Trump EO to Ease Access to Psychedelics Bloomberg —
- Trump’s order on psychedelics could have far-reaching science consequences Scientific American —
- Trump’s call to deregulate psychedelics boosts drugmakers’ shares Financial Times —
- Psychedelic Stocks Soar as Trump Signs Order to Ease Access Bloomberg —
- How Trump's psychedelics executive order could unlock stalled cannabis reform CNBC —
- Trump administration moves forward with certain drug reclassifications CBS News —
- Trump administration moves forward with certain drug reclassifications CBS News —
- Trump Signs Psychedelic Drugs Order. 4 Stocks That Are Surging. Barrons —
- Trump Signs Order to Fast-Track Psychedelic Drugs. AtaiBeckley and These Other Stocks Are Soaring. Barrons —
- Psychedelic drug developers rally as Trump orders FDA to expedite reviews - Reuters Reuters —
- Cybin stands out as the most undervalued psychedelic stock as Trump signs on faster PTSD research Seeking Alpha —
AtaiBeckley
Trump signs order on psychedelics